Thyroid cancer: are molecular studies making any difference?

D S Kim1

  • 1Department of Otolaryngology, University Hospital Birmingham, UK. Daekim72@yahoo.co.uk

Insights

This review highlights advances in translational research, particularly in thyroid disease. It showcases successful applications of basic science discoveries to clinical practice, offering hope for future treatments.

Area of Science:

  • Biomedical Sciences
  • Genetics
  • Molecular Biology

Background:

  • Translational research bridges basic science discoveries and clinical applications.
  • Significant progress in molecular biology and genetics has occurred in the last decade.
  • The human genome project and high-throughput technologies have accelerated data accumulation.

Purpose of the Study:

  • To discuss major scientific developments relevant to translational research.
  • To showcase successful examples of translational research in thyroid disease.
  • To summarize recent thyroid disease research for future clinical tools.

Main Methods:

  • Review of scientific literature and recent research findings.
  • Analysis of successes in applying basic science to otolaryngology and thyroid disease.
  • Discussion of advancements in genomics and proteomics.

Main Results:

  • Herceptin and Avastin exemplify successful drug translation.
  • Otolaryngology has seen successful science-to-clinic translation.
  • Thyroid disease research shows promise for new clinical tools.

Conclusions:

  • Advancements in molecular biology and genetics are crucial for translational research.
  • Thyroid translational research has demonstrated successes.
  • Emerging research offers hope for improved thyroid disease management.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...